Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cemex SAB de CV (ADR) (CX), Texas Industries, Inc. (TXI): Three Cement Companies to Consider in a Recovery

Page 1 of 2

The low growth in the U.S. economy has been hitting the balance sheets of cement companies for the past five years. This industry is highly correlated to mid- and long-term construction investment levels, which were severely damaged with the credit crunch and housing crisis. Currently, income and gains are modest for this sector, but the incipient recovery for home builders could begin to improve the industry’s performance.

I will analyze three cement companies to see how they are positioned to realize future growth.

The cement giant still weak

Cemex SAB de CV (ADR)
Cemex SAB de CV (ADR) (NYSE:CX) is one of the world’s largest cement producers and the number one in sales of cement and ready-mix concrete in the U.S.

Currently, the company is experiencing weak demand for cement and concrete mainly in Europe, where 27% of its revenue is generated. In spite of the little growth in U.S. sales, its first-quarter results still show weak profits. The company posted a loss of $265.3 million, a lot wider than the $29.9 million loss experienced in the first quarter of 2012. Net margin was -8%, a tenuous performance compared to the rest of the cement industry, which is at 3%, and to its own historical performance.

In 2007 the company acquired the Australian cement company Rinker Group, which  operates in Australia, China and the states of Florida and Arizona under the name “Florida Materials”. To complete this acquisition, Cemex SAB de CV (ADR) (NYSE:CX) took on a large amount of debt, and had to sell some attractive assets that could affect its competitive position.

Unfortunately, after the acquisition, the downfall in the construction activity put the company in a unhealthy financial situation. Its cash-to-debt ratio is slightly less than 0.1, much lower than the rest of the industry (0.5). This means that the company could not hold another long recession without refinancing its debt.

Texas Industries, Inc. (NYSE:TXI)In a steady expansion and prepared for the recovery

Texas Industries, Inc. (NYSE:TXI) is a leading supplier of cement, aggregate and consumer product building materials for the Texas and California markets, the two largest cement markets in the U.S.

The company is executing a steady expansion initiative and investing in modernizing plants to lower costs. In March, Texas Industries, Inc. (NYSE:TXI) announced the expansion of its shale and clay aggregates manufacturing business, providing materials to the energy and construction sectors. Texas Industries, Inc. (NYSE:TXI) recently finalized the construction of a new kiln at its main plant in Texas, which increased its production capacity by 1.4 million tons.

The company managed to triple its capacity in the past 15 years, going from 2 million tons to 6 million tons in year-to-date.

However, the company’s balance sheet is not yet showing much optimism. Results for the first quarter of 2013 posted a net loss of $5.8 million, which improved compared to the prior-year’s net loss of $24.3 million but is still a factor of concern. Texas Industries, Inc. (NYSE:TXI)’ $650 million debt load still remains a problem, especially when the company keeps losing money. Its cash-to-debt ratio is 0.1, lower than the the industry average, so the company will face tougher times if construction does not pick up soon.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!